OvaScience (OVAS) Misses Q3 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. SBUX
10. SNDK

Go back to OvaScience (OVAS) Misses Q3 EPS by 5c

OvaScience Reports Fourth Quarter and Year-End 2015 Financial Results

February 25, 2016 4:00 PM EST

Harald Stock, Ph.D., Appointed as CEO-Elect, Paul Chapman Appointed as COO to Expand Global Commercial and Operational Expertise

Egg Allocation Study Commenced in Spain

Access to the AUGMENTSM Treatment Expanded to Japan

In 2016 OvaScience Will Continue to Build Global Infrastructure to Support Its Fertility Platform in Select Regions

WALTHAM, Mass.--(BUSINESS WIRE)-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today reported fourth quarter and year end 2015 financial results. The Company also highlighted key... More